MassDevice

Resmed posts Street-beating Q2 results amid increased CPAP demand

Resmed (NYSE: RMD) shares ticked up before hours today on second-quarter results that came in ahead of the consensus forecast ...

ResMed beats quarterly profit estimates on strong demand for its sleep devices

By Siddhi Mahatole Jan 29 (Reuters) - Medical device maker ResMed on Thursday beat Wall Street estimates for second-quarter ...
Yahoo Finance

UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ...
Investing.com South Africa

ResMed shares rise 2% as Q2 earnings top estimates, margins improve

For the quarter ended December 31, 2025, ResMed reported adjusted earnings per share of $2.81, exceeding analyst estimates of $2.73. Revenue increased 11% to $1.4 billion, in line with consensus ...
Business Wire

ResMed Debuts AirTouch N20 Foam CPAP Mask, Its Softest Nasal Mask Ever

ResMed’s first nasal memory foam cushion enhances patients’ comfort and convenience, doesn’t need cleaning when replaced on an appropriate schedule AirTouch N20 is the latest offering in ResMed’s line ...
Business Wire

ResMed’s First Top-of-Head CPAP Mask, AirFit N30i, Now Available across U.S.

AirFit N30i adds a top-of-head mask-to-tube connection to ResMed’s expanding CPAP mask portfolio, helps the wearer move and sleep in any position New “cradle” cushion sits under the nose, designed to ...
Healio

ResMed CPAP masks subject to Class I recall over magnetic interference issue

Please provide your email address to receive an email when new articles are posted on . ResMed CPAP masks that contain magnets are being recalled due to possible magnetic interference with medical ...

ResMed outlines 62%–63% gross margin target for fiscal 2026 amid double-digit growth in key segments

Q2 FY2026 earnings call recap: 11% revenue growth, margin expansion, AI innovation, and updated 62–63% guidance—read key takeaways now.
Yahoo Finance

ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ...